Showing results (111-120 of 122) with videos related to
Sort By:
Pageof 13
Alcoholism, Clinical and Experimental Research|June 1, 1994
Abstinent alcoholics exhibit an exaggerated stress response to 2-deoxy-D-glucose challengeD T George, T Lindquist, T Alim, et al.Journal of Pediatric Orthopedics|September 1, 1989
Three-dimensional digital displays in congenital dislocation of the hip: preliminary experienceP Lang, H K Genant, P Steiger, et al.Biological Psychiatry|December 5, 1997
Effect of alcoholism on the incidence of lactate-induced panic attacksD T George, T Lindquist, P W Ragan, et al.Journal of Computer Assisted Tomography|May 1, 1988
Three-dimensional CT and MR imaging in congenital dislocation of the hip: clinical and technical considerationsP Lang, P Steiger, H K Genant, et al.Clinical Neuropharmacology|April 1, 1992
Effect of a low-tryptophan diet as an adjuvant to conventional neuroleptic therapy in schizophreniaR B Rosse, B L Schwartz, S Zlotolow, et al.European Journal of Pharmacology|February 24, 1995
The effects of adenosine A3 receptor stimulation on seizures in miceD K Von Lubitz, M F Carter, S I Deutsch, et al.Biological Psychiatry|December 1, 1983
Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease and normalsS I Deutsch, R C Mohs, M I Levy, et al.Clinical Neuropharmacology|August 1, 1995
Famotidine adjunctive pharmacotherapy of schizophrenia: a case reportR B Rosse, K Kendrick, L C Tsui, et al.Clinical Neuropharmacology|August 1, 1996
An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacyR B Rosse, K Kendrick, M Fay-McCarthy, et al.Clinical Pharmacology and Therapeutics|November 1, 1992
Pharmacologic maintenance of abstinence in patients with alcoholism: no efficacy of 5-hydroxytryptophan or levodopaD T George, T Lindquist, R R Rawlings, et al.Pageof 13